Cite
HARVARD Citation
Tamiya, A. et al. (n.d.). 3079 Randomized phase II trial of amrubicin plus irinotecan versus cisplatin plus irinotecan in chemo-naïve patients with extensivedisease small-cell lung cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01. European journal of cancer. pp. S623-S624. [Online].